Cell kinetic characterization of cultured human keratinocytes from normal and psoriatic individuals

Journal of Cellular Physiology

Volumn 168, Issue 3, 1996, Pages 684-694

  Van Ruissen, Fred ^a   De Jongh, Gijs J ^a   Van Erp, Piet E J ^a   Boezeman, Jan B M ^a   Schalkwijk, Joost ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL CYCLE; CELL CYCLE PARAMETERS; CELL GROWTH; CELL KINETICS; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; KERATINOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS;

CELL CYCLE; CELLS, CULTURED; CULTURE MEDIA; EPIDERMIS; HUMANS; KERATINOCYTES; PSORIASIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029743002     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199609)168:3<684::AID-JCP21>3.0.CO;2-Y     Document Type: Article

References (62)

1. Alkemade, J.A., Molhuizen, H.O., Ponec, M., Kempenaar, J.A., Zeeuwen, P.L., de Jongh, G.J., van Vlijmen Willems, I.M., Van Erp, P.E., van de Kerkhof, P.C., and Schalkwijk, J. (1994) SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes. J. Cell Sci., 107:2335-2342.
2. Baadsgaard, O., Fisher, G., Voorhees, J.J., and Cooper, K.D. (1990) The role of the immune system in the pathogenesis of psoriasis. J. Invest. Dermatol., 95:32S-34S.
3. Baker, B.S., Swain, A.F., Valdimarsson, H., and Fry, L. (1984) T-cell subpopulations in the blood and skin of patients with psoriasis. Br. J. Dermatol., 110:37-44.
4. Bata-Csorgo, Z., Hammerberg, C., Voorhees, J.J., and Cooper, K.D. (1993) Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis. J. Exp. Med., 178:1271-1281.
5. Bata-Csorgo, Z., Hammerberg, C., Voorhees, J.J., and Cooper, K.D. (1995) Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes. J. Clin. Invest., 95:317-327.
6. Bauer, F.W., and Boezeman, J.B.M. (1983) Flow cytometric methods in human skin with respect to cell cycle kinetics. In: Psoriasis: Cell Proliferation. Vol. 1. N.A. Wright and R.S. Camplejohn, eds. Churchill Livingstone, Edinburgh, pp. 104-116.
7. Begg, A.C., McNatty, N.J., and Shrieve, D.C.K. (1985) A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry, 6:620-626.
8. Bernard, B.A., Asselineau, D., Schaffar Deshayes, L., and Darmon, M.Y. (1988) Abnormal sequence of expression of differentiation markers in psoriatic epidermis: Inversion of two steps in the differentiation program? J. Invest. Dermatol., 90:801-805.
9. 0 cells in human epidermis in vivo following tape stripping. Cell Tissue Kinet. 20:90-107.
10. Braverman, I.M., and Sibley, J. (1982) Role of the microcirculation in the treatment and pathogenesis of psoriasis. J. Invest. Dermatol., 78:12-17.
11. Cook, P.W., Pittelkow, M.R., Keeble, W.W., Graves Deal, R., Coffey, R.J., Jr., and Shipley, G.D. (1992) Amphiregulin messenger RNA is elevated in psoriatic epidermis and gastrointestinal carcinomas. Cancer Res., 52:3224-3227.
12. de Jong, E.M., van Vlijmen, I.M., Van Erp, P.E., Ramaekers, F.C., Troyanoyski, S.M., and van de Kerkhof, P.C. (1991) Keratin 17: A useful marker in anti-psoriatic therapies. Arch. Dermatol. Res., 283:480-482.
13. De Mare, S., van Erp, P.E.J., and van de Kerkhof, P.C.M. (1989) Epidermal hyperproliferation assessed by the monoclonal antibody Ks8.12 on frozen sections. J. Invest. Dermatol., 92:130-131.
14. Dover, R. (1994) Cell kinetics of keratinocytes. In: The Keratinocyte Handbook. E.B. Lane, I.M. Leigh, and F.M. Watt, eds. Cambridge University Press, Cambridge, pp. 203-234.
15. Eaglstein, W.H., and Weinstein, G.D. (1975) Prostaglandin and DNA synthesis in human skin: Possible relationship to ultraviolet light effects. J. Invest. Dermatol., 64:386-389.
16. Elder, J.T., Fisher, G.J., Lindquist, P.B., Bennett, G.L., Pittelkow, M.R., Coffey, R.J., Jr., Ellingsworth, L., Derynck, R., and Voorhees, J.J. (1989) Overexpression of transforming growth factor-alpha in psoriatic epidermis. Science, 243:811-814.
17. Elder, J.T., Ellingsworth, L.R., Fisher, G.J., and Voorhees, J.J. (1990) Transforming growth factor-beta in psoriasis. Pathogenesis and therapy. Ann. N.Y. Ac. Sci., 593:218-230.
18. Elder, J.T., Nair, R.P., and Voorhees, J.J. (1994) Epidemiology and the genetics of psoriasis. J. Invest. Dermatol., 102:24S-27S.
19. Gelfant, S. (1976) The cell cycle in psoriasis: A reappraisal. Br. J. Dermatol., 95:577-590.
20. Gelfant, S. (1982) On the existence of non-cycling germinative cells in human epidermis in vivo and cell cycle aspects of psoriasis. Cell Tissue Kinet., 15:393-397.
21. Gentleman, S., Martensen, T.M., Digiovanna, J.J., and Chader, G.J. (1984) Protein tyrosine kinase and protein phosphotyrosine phosphatase in normal and psoriatic skin. Biochim. Biophys. Acta, 798:53-59.
22. Gottlieb, A.B. (1990) Immunologic mechanisms in psoriasis. J. Invest. Dermatol., 95:18S-19S.
23. 389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nature Medicine, 1:442-447.
24. Grossman, R.M., Krueger, J., Yourish, D., Granelli-Piperno, A., Murphy, D.P., May, L.T., Kupper, T.S., Sehgal, P.B., and Gottlieb, A.B. (1989) Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc. Natl. Acad. Sci. U. S. A., 86:6367-6371.
25. Hammar, H., Gu, S.Q., Johannesson, A., Sundkvist, K.G., and Biberfeld, P. (1984) Subpopulations of mononuclear cells in microscopic lesions of psoriatic patients. Selective accumulation of suppressor/ cytotoxic T cells in epidermis during the evolution of the lesion. J. Invest. Dermatol., 83:416-420.
26. Hammerberg, C., Arend, W.P., Fisher, G.J., Chan, L.S., Berger, A.E., Haskill, J.S., Voorhees, J.J., and Cooper, K.D. (1992) Interleukin-1 receptor antagonist in normal and psoriatic epidermis. J. Clin. Invest., 90:571-583.
27. Hertle, M.D., Kubler, M.D., Leigh, I.M., and Watt, F.M. (1992) Aberrant integrin expression during epidermal wound healing and in psoriatic epidermis. J. Clin. Invest., 89:1892-1901.
28. Johansson, M., Baldetorp, B., Bendahl, P.O., Johansson, R., and Oredsson, S. (1994) An improved mathematical method to estimate DNA synthesis time of BrdUrd-labelled cells, using FCM-derived data. Cell Prolif., 27:75-488.
29. Jones, P.H., and Watt, F.M. (1993) Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell, 73:713-724.
30. Kragballe, K., Desjarlais, L., and Marcelo, C.L. (1985) Increased DNA synthesis of uninvolved psoriatic epidermis is maintained in vitro. Br. J. Dermatol., 112:263-270.
31. Leung, D.Y., Walsh, P., Giorno, R., and Norris, D.A. (1993) A potential role for superantigens in the pathogenesis of psoriasis. J. Invest. Dermatol., 100:225-228.
32. Madsen, P., Rasmussen, H.H., Leffers, H., Honore, B., Dejgaard, K., Olsen, E., Kill, J., Walbum, E., Andersen, A.H., Basse, B., Launidsed, J.B., Ratz, G.P., Celis, A., van de Kerchhove, J., and Celis, J.E. (1991) Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J. Invest. Dermatol., 97:701-712.
33. Madsen, P., Rasmussen, H.H., Leffers, H., Honore, B., and Celis, J.E. (1992) Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins. J. Invest. Dermatol., 99:299-305.
34. Matsumoto, K., Hashimoto, K., Hashiro, M., Yoshimasa, H., and Yoshikawa, K. (1990) Modulation of growth and differentiation in normal human keratinocytes by transforming growth factor-beta. J. Cell Physiol., 145:95-101.
35. Michel, S., Bernerd, F., Jetten, A.M., Floyd, E.E., Shroot, B., and Reichert, U. (1992) Expression of keratinocyte transglutamine mRNA revealed by in situ hybridization. J. Invest. Dermatol., 98:364-368.
36. Molhuizen, H.O., Alkemade, H.A., Zeeuwen, P.L., de Jongh, G.J., Wieringa, B., and Schalkwijk, J. (1993) SKALP/elafin: An elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking. J. Biol. Chem., 268:12028-12032.
37. Moses, H.L., Coffey, R.J., Jr., Leof, E.B., Lyons, R.M., and Keski Oja, J. (1987) Transforming growth factor beta regulation of cell proliferation. J. Cell. Physiol., Suppl. 5:1-7.
38. Nanney, L.B., Stoscheck, C.M., Magid, M., and King, L.E. (1986) Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis. J. Invest. Dermatol., 86:260-265.
39. Nanney, L.B., Yates, R.A., and King, L.E. (1992) Modulation of epidermal growth factor receptors in psoriatic lesions during treatment with topical EGF. J. Invest. Dermatol., 95:296-301.
40. Nickoloff, B.J., Karabin, G.D., Barker, J.N., Griffiths, C.E., Sarma, V., Mitra, R.S., Elder, J.T., Kunkel, S.L., and Dixit, V.M. (1991) Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am. J. Pathol., 138:129-140.
41. Pellegrini, G., de Luca, M., Orecchia, G., Balzac, F., Cremona, O., Savoia, P., Cancedda, R., and Marchisio, P.C. (1992) Expression, topography, and function of integrin receptors are severely altered in keratinocytes from involved and uninvolved psoriatic skin. J. Clin. Invest., 89:1783-1795.
42. Reiss, M., and Sartorelli, A.C. (1987) Regulation of growth and differentiation of human keratinocytes by type beta transforming growth factor and epidermal growth factor. Cancer Res., 47:6705-6709.
43. Rheinwald, J.G., and Green, H. (1975) Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells. Cell, 6:331-344.
44. Rijzewijk, J.J., van Erp, P.E.J., and Bauer, F.W. (1989) Two binding sites for Ki67 related to quiescent and cycling cells in human epidermis. Acta Derm. Venereol. (Stockholm), 69:512-515.
45. Schalkwijk, J., Chang, A., Janssen, P., de Jongh, G.J., and Mier, P.D. (1990) Skin-derived antileucoproteases (SKALPs): Characterization of two new elastase inhibitors from psoriatic epidermis. Br. J. Dermatol., 122:631-641.
46. Schmid, P., Cox, D., McMaster, G.K., and Itin, P. (1993) In situ hybridization analysis of cytokine, proto-oncogene and tumor suppressor gene expression in psoriasis. Arch. Dermatol. Res., 285:334-340.
47. Shipley, G.D., and Pittelkow, M.R. (1987) Control of growth and differentiation in vitro of human keratinocytes cultured in serum-free medium. Arch. Dermatol., 123:1541a-1544a.
48. Shipley, G.D., Pittelkow, M.R., Wille, J.J., Scott, R.E., and Moses, H.L. (1986) Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium. Cancer Res., 46:2068-2071.
49. Tettelbach, W., Nanney, L., Ellis, D., King, L., and Richmond, A. (1993) Localization of MGSA/GRO protein in cutaneous lesions. J. Cutan. Pathol., 20:259-266.
50. Turbitt, M.L., Akhurst, R.J., White, S.I., and MacKie, R.M. (1990) Localization of elevated transforming growth factor-alpha in psoriatic epidermis. J. Invest. Dermatol., 95:229-232.
51. van de Kerkhof, P.C.M. (1986) Clinical features. In: Textbook of Psoriasis. P.D. Mier and P.C.M. Van de Kerkhof, eds. Churchill Livingstone, Edinburgh, pp. 13-39.
52. van Erp, P.E.J., Brons, P.P.T., Boezeman, J.B.M., de Jongh, G.J., and Bauer, F.W. (1988) A rapid flow cytometric method for bivariate bromodeoxyuridine/DNA analysis using simultaneous proteolytic enzyme digestion and acid denaturation. Cytometry, 9:627-630.
53. van Erp, P.E.J., De Mare, S., Rijzewijk, J.J., van de Kerkhof, P.C.M., and Bauer, F.W. (1989) A sequential double immunoenzymic staining procedure to obtain cell kinetic information in normal and hyperproliferative epidermis. Histochem. J., 21:343-347.
54. van Erp, P.E.J., Boezeman, J.B.M., and Brons, P.P.T. (1991) Cell cycle kinetics in human skin by in vivo administration of iododeoxyuridine and application of a differentiation marker. Cytometry, Suppl 5:76(Abstract).
55. van Ruissen, F., van Erp, P.E.J., de Jongh, G.J., Boezeman, J.B.M., van de Kerkhof, P.C.M., and Schalkwijk, J. (1994) Cell kinetic characterization of growth arrest in cultured human keratinocytes. J. Cell Sci., 107:2219-2228.
56. Watt, F.M. (1988) Epidermal stem cells in culture. J. Cell Sci. Suppl., 10:85-94.
57. Watt, F.M., and Jones, P.H. (1993) Expression and function of the keratinocyte integrins. Dev. Suppl., 185-192.
58. Weinstein, G.D., and van Scott, E.J. (1965) Autoradiographic analysis of turnover times of normal and psoriatic epidermis. J. Invest. Dermatol., 45:257-262.
59. Weiss, R.A., Eichner, R., and Sun, T.-T. (1984) Monoclonal antibody analysis of keratin expression in epidermal diseases: A 48- and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes. J. Cell Biol., 98:1397-1406.
60. Wilke, M.S., Edens, M., and Scott, R.E. (1988a) Ability of normal human keratinocytes that grow in culture in serum-free medium to be derived from suprabasal cells. J. Natl. Cancer Inst., 80:1299-1304.
61. Wilke, M.S., Hsu, B.M., Wille, J.J., Pittelkow, M.R., and Scott, R.E. (1988b) Biologic mechanisms for the regulation of normal human keratinocyte proliferation and differentiation. Am. J. Path., 131:171-181.
62. Wille, J.J., Pittelkow, M.R., Shipley, G.D., and Scott, R.E. (1984) Integrated control of growth and differentiation of normal human prokeratinocytes cultured in serum-free medium: Clonal analysis, growth kinetics, and cell cycle studies. J. Cell. Physiol., 121:31-44.